Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities
Myron S. Cohen(University of North Carolina at Chapel Hill), Jason Morris, Carl J. Fichtenbaum(Cancer Research And Biostatistics), Leandro Mena(Emory University), Meredith E. Clement(Louisiana State University Health Sciences Center New Orleans), Jacob Van Naarden(Eli Lilly (United States)), Srilatha Edupuganti(Emory University), Jason Begue, Richard Novák(Illinois College), Russell J. McCulloh(Children's Mercy Hospital), Jack Knorr(Eli Lilly (United States)), Greer Burkholder, Scott Borgetti, Blair Brengle, V. G. Horstman, Kenneth L. Custer(Eli Lilly (United States)), C. Brendan Montano, Paul Klekotka(Eli Lilly (United States)), Alexander Stemer(Indiana University Northwest), Ajay Nirula(Eli Lilly (United States)), Brad Lipson, Karen Price(Eli Lilly (United States)), Jennifer Farrior(Family Health International 360), Lei Shen(Shanghai Jiao Tong University), Stockton Mayer(Illinois College), Daniel Skovronsky, Catherine Yen(National Institutes of Health), Julio A. Ramírez(University of Louisville), Nirupama Sista(Family Health International 360), Rubaba Hussain, Margarita M. Gomez Lorenzo(Norwegian Womens Public Health Association), Matan C. Dabora(Eli Lilly (United States)), David A. Wohl(University of North Carolina at Chapel Hill), Jay Tuttle(Eli Lilly (United States)), Mark J. Mulligan(New York University), Ian Frank(Norwegian Womens Public Health Association), Brian T. Montague(University of Colorado Denver), Christopher J. Hall(Babraham Institute), Wairimu Chege(National Institutes of Health), Janelle Sabo(Eli Lilly (United States)), Mary Marovich(University of Maryland, Baltimore), Nashwa Gabra(Burke Foundation), Elizabeth R. Brown(Fred Hutch Cancer Center), Andrew C. Adams(Beth Israel Deaconess Medical Center), Kwadwo-Agyei Gyamfi, Tina Merritt, Andrew E. Schade(Case Western Reserve University), Kathleen Gannon, Christine Thai(Frequency Management International (United States))
Cited by 208
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Assessing differential impacts of COVID-19 on black communities
|Annals of Epidemiology|2020|1.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847